Literature DB >> 8349985

Treatment of posttraumatic radioulnar synostosis with excision and low-dose radiation.

R A Abrams1, B P Simmons, R A Brown, M J Botte.   

Abstract

Two cases of posttraumatic radioulnar synostosis treated with excision and low-dose radiation are presented. Routine postoperative hand therapy was employed. Nearly full range of motion was restored in both cases. No wound healing problems were encountered. We suggest that low-dose radiation may be a useful method of prophylaxis against recurrence after excision of radioulnar synostosis.

Entities:  

Mesh:

Year:  1993        PMID: 8349985     DOI: 10.1016/0363-5023(93)90322-T

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  5 in total

1.  The clinical implications of heterotopic ossification in patients treated with radial head replacement for trauma: A case series and review of the literature.

Authors:  Seth H Bowman; William R Barfield; Harris S Slone; Gerald J Shealy; Zeke J Walton
Journal:  J Orthop       Date:  2016-06-28

2.  Comparing Options for Heterotopic Ossification Prophylaxis following Elbow Trauma: A Systematic Review and Meta-Analysis.

Authors:  Jeffrey M Henstenburg; Matthew Sherman; Asif M Ilyas
Journal:  J Hand Microsurg       Date:  2020-12-31

3.  The Posttraumatic Proximal Cross-union of the Forearm in Childhood: What is Recommended?

Authors:  Marcel Dudda; Tobias Fehmer; Thomas A Schildhauer; Christiane Kruppa
Journal:  Orthop Rev (Pavia)       Date:  2013-06-18

4.  Appropriate excision time of heterotopic ossification in elbow caused by trauma.

Authors:  Shu-Kun He; Min Yi; Gang Zhong; Shi-Qiang Cen; Jia-Lei Chen; Fu-Guo Huang
Journal:  Acta Orthop Traumatol Turc       Date:  2017-12-28       Impact factor: 1.511

Review 5.  The timing of open surgical release of post-traumatic elbow stiffness: A systematic review.

Authors:  Chao Sun; Xijie Zhou; Chenglun Yao; Keshav Poonit; Cunyi Fan; Hede Yan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.